Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by eric40on Apr 02, 2018 10:09am
237 Views
Post# 27814029

RE:Outta of dry powder!! shoot.

RE:Outta of dry powder!! shoot.Lower price might also be coming... 

There will be pressure from the shorts and the underwritter to keep it as low as possible. And since I see no catalist news other than a deal (and man we are in such a weak position even with great science data), the shorts and underwritter have all they need thanks to uncertainty for the cash and credibility crisis. 

But they will get through this crisis with probably a sizable dilution or a deal or a deal plus dilution.

Time will tell. Buckle up 


Bullboard Posts